CAR NK Cells

CAR NK Cells

Chimeric Antigen Receptor (CAR) NK Cells: Alphageneron is developing ‘off-the- shelf’ umbilical cord (UC) blood- and induced pluripotent stem cell (iPSC)-derived CAR-engineered NK (CAR NK) cell-based cancer therapeutics that target tumors expressing mHsp70, and other (undisclosed) targets.

 

Gene editing of allogeneic CAR NK cells will be used to improve persistence, potency, and efficacy.